Where I see patients (1)
My reviews
Selected research
- 
							Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.
							Multiple sclerosis (Houndmills, Basingstoke, England)
- 
							Cognitive Function in People With Pediatric Multiple Sclerosis Over 2 Years.
							Neurology
- 
							Evaluating Efficacy Outcomes in Pediatric Multiple Sclerosis Patients While Using Avonex or Plegridy via USNPMSC Registry.
							Journal of child neurology
 
					
				
 
														 
														 
														 
														 
														 
				
					 
				
4.9